Cefadroxil Powder, For Suspension
Product Images NDC 57237-097

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefadroxil (NDC 57237-097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg/5 mL (100 mL WHEN MIXED))

This is a description of Cefadroxil, which is a type of medication available in suspension form. The text provides instructions on how to prepare the suspension by mixing the medicine with water, and how to store it. It also mentions the dosage and possible allergic reactions. The medication is distributed by Rising Health, LLG located in Saddle Brook, NJ and made in India.*

FDA Label Image

Package Label-principal Display Panel (500 mg/5 mL (100 mL WHEN MIXED))

This is a description of the medication Cefadroxil for Oral Suspension. The text provides instructions for preparing the suspension, its recommended dosage, and storage requirements. The usual dose is not specified and must be consulted in the accompanying prescribing information. It also contains a warning that the medication contains sulfur dioxide, and that unused portions should be discarded after 14 days. The manufacturer is identified as Rising Health LLC and the medication is made in India.*

FDA Label Image

Chemical Structure (Cefadroxil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.